BackImmune Disorders: Hypersensitivity and Autoimmunity
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Immune Disorders
Overview of Hypersensitivity and Autoimmunity
Immune disorders arise when the immune system's response is either exaggerated or misdirected, leading to tissue damage or dysfunction. Two major categories are hypersensitivity reactions and autoimmune diseases. Hypersensitivity refers to inappropriate or excessive immune responses to antigens, while autoimmunity involves immune attacks against the body's own tissues.
Types of Hypersensitivity Reactions
Classification and Characteristics
There are four main types of hypersensitivity reactions, each with distinct mechanisms, time courses, and cellular mediators. Understanding these types is crucial for diagnosing and managing immune-related diseases.
Type | Name | Cause | Time Course | Characteristic Cells Involved |
|---|---|---|---|---|
I | Immediate hypersensitivity | Antibody (mainly IgE) on sensitized cells interacts with allergens, causing degranulation | After initial sensitization, seconds to minutes | Previously sensitized mast cells or basophils |
II | Cytotoxic hypersensitivity | Antibodies and complement lyse target cells | Minutes to hours | Plasma cells secrete antibodies that act against other body cells |
III | Immune complex–mediated hypersensitivity | Nonphagocytized complexes of antibody and antigen trigger complement activation, leading to inflammation | Several hours | Neutrophils |
IV | Delayed (cell-mediated) hypersensitivity | T cells attack the body's cells | Several days | Activated T cells |

Type I (Immediate) Hypersensitivity
Type I hypersensitivity, also known as anaphylactic or allergic reactions, occurs rapidly after exposure to an allergen. It involves the release of inflammatory mediators from mast cells and basophils that have been sensitized by IgE antibodies.
Key Point: Allergens are antigens that provoke allergic responses.
Examples: Pollen, dust mites, and certain foods are common allergens.

Mechanism: Sensitization and Degranulation
Sensitization: Initial exposure to an allergen leads to IgE production, which binds to mast cells and basophils.
Degranulation: Upon subsequent exposure, the allergen cross-links IgE on these cells, triggering the release of histamine and other mediators.


Type II (Cytotoxic) Hypersensitivity
Type II hypersensitivity involves the destruction of cells by antibodies (usually IgG or IgM) and complement. This reaction is central to certain autoimmune diseases and transfusion reactions.
Key Point: Antibodies bind to antigens on the surface of target cells, leading to cell lysis.
Examples: Hemolytic transfusion reactions, hemolytic disease of the newborn (Rh incompatibility).

ABO Blood Group and Transfusion Reactions
Transfusion of incompatible blood can result in antibody-mediated destruction of donor red blood cells.
ABO Blood Group | ABO Antigen(s) Present | Antibodies Present | Can Donate To | Can Receive From |
|---|---|---|---|---|
A | A | Anti-B | A or AB | A or O |
B | B | Anti-A | B or AB | B or O |
AB | A and B | None | AB | A, B, AB, or O (universal recipient) |
O | None | Both anti-A and anti-B | A, B, AB, or O (universal donor) | O |


Rh System and Hemolytic Disease of the Newborn
The Rh antigen is present in most humans. If an Rh-negative mother carries an Rh-positive fetus, she may develop antibodies that attack fetal red blood cells in subsequent pregnancies, causing hemolytic disease of the newborn. Administration of RhoGAM prevents this response.

Type III (Immune Complex–Mediated) Hypersensitivity
Type III hypersensitivity is caused by the formation of immune complexes (antigen-antibody complexes) that deposit in tissues, triggering inflammation and tissue damage.
Key Point: Immune complexes activate complement and attract neutrophils, leading to tissue injury.
Examples: Systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), glomerulonephritis.

Type IV (Delayed or Cell-Mediated) Hypersensitivity
Type IV hypersensitivity is mediated by T cells rather than antibodies. The response is delayed, typically appearing 12–24 hours after antigen exposure.
Key Point: T cells and macrophages are the main effectors, causing tissue damage at the site of antigen exposure.
Examples: Tuberculin skin test, contact dermatitis, graft rejection.

Autoimmune Diseases
Overview and Causes
Autoimmune diseases occur when the immune system attacks the body's own tissues. These diseases are more common in the elderly and in women. The mechanisms underlying autoimmunity are complex and multifactorial.
Key Point: Autoimmunity may result from the production of autoantibodies or cytotoxic T cells against self-antigens.
Examples: Type I diabetes, rheumatoid arthritis, lupus, multiple sclerosis.
Hypotheses for the Causes of Autoimmunity
Estrogen may stimulate cytotoxic T cell activity against self-tissues.
Maternal or fetal cells crossing the placenta may trigger autoimmunity later in life.
Environmental factors, such as viral infections, may initiate autoimmune responses.
Genetic predisposition, especially certain MHC genes, increases risk.
T cells may encounter self-antigens that are normally hidden from the immune system.
Molecular mimicry: Microbial antigens resemble self-antigens, leading to cross-reactivity.
Failure of normal immune regulatory mechanisms.
Criteria for a Good Vaccine
Key Features of Effective Vaccines
Induces a strong and lasting immune response (immunogenicity).
Provides long-term protection (memory response).
Is safe, with minimal side effects.
Is stable and easy to administer.
Is affordable and accessible to the target population.
Does not cause disease in immunized individuals.
Summary Table: Hypersensitivity Types
Type | Mechanism | Example Diseases |
|---|---|---|
I | IgE-mediated, mast cell degranulation | Allergies, anaphylaxis |
II | Antibody-mediated cytotoxicity | Hemolytic anemia, transfusion reactions |
III | Immune complex deposition | Lupus, rheumatoid arthritis |
IV | T cell-mediated, delayed response | Contact dermatitis, graft rejection |